What Pharma Marketers Need to Know About Google’s Latest Cookie Deprecation Update

After recently extending its cookie deprecation timeline for the third time, Google has announced that it will move in a different direction. Instead of deprecating third-party cookies, Google plans to “introduce a new experience in Chrome that lets people make an informed choice that applies across their web browsing.”

Although advertisers might feel relieved by this announcement, it doesn’t render a cookieless future obsolete. As DeepIntent Founder and CEO Chris Paquette shared in his recent LinkedIn post, “It’s important to note that this decision is not an abandonment of Google’s intention to change the web browsing experience in the name of privacy. In the same blog post, Google remains clear that it will continue to pursue development of the Privacy Sandbox.”

In the face of a rapidly changing privacy landscape, we still recommend that advertisers continue testing and developing alternative approaches to identity. DeepIntent remains steadfast in its commitment to maintaining a privacy-safe environment. That’s why we continue to invest in and test solutions that do not rely on third-party cookies. Here’s what you need to know about our plans moving forward.

Our Preparation for Cookie Deprecation Continues

After Google’s announcement, DeepIntent’s plans for cookie deprecation remain unchanged. We will continue to target and measure using whichever identifiers are available in the bid stream, which for now will include third-party cookies. However, our solutions do not rely on them.

Only time will tell whether third-party cookies will, eventually, disappear from digital advertising. For now, we remain focused on innovating for the future of health advertising, allowing advertisers to activate using persistent and sustainable signals independent of Google’s plans for cookie deprecation. Strengthening our strategies and testing new ones is critical for guaranteeing powerful, ethical advertising in a more privacy-centric landscape.

Looking for an alternative to third-party cookies? Here are two questions you should ask your DSP about going cookieless.

Share this Post

Related Articles

AdLab 2025’s final panel brought together top healthcare marketing leadership to discuss the groundbreaking, women-led innovations shaping our industry, and how women leaders are strengthening their company cultures. DeepIntent Chief Revenue Officer Lisa Kopp Johnson moderated the panel, which featured Nicole Hamlin, Group Director, Integrated Planning at Butler/Till; Andrea Palmer, Chief Executive Officer at Publicis […]

In an age when information overload and medical misinformation are rampant, ensuring equitable access to accurate, timely health information has never been more urgent. The disparities in healthcare, driven by cultural, socioeconomic, and geographic divides, are well-documented. But as the latest research reveals, healthcare advertising is uniquely positioned to help close these gaps and improve […]

One of the most exciting conversations at AdLab 2025 was the panel, “AI in Health Marketing: Real-World Strategies, Use Cases, and Ethics.” As AI continues to reshape how healthcare marketers target, optimize, and engage, panelists cut through the noise to explore what’s actually working and what’s most promising. Moderated by DeepIntent Chief Technology Officer Anton […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.